Updated:
TETRAPHASE PHARMACEUTICALS INC
TETRAPHASE PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001373707, and its reported...
Overview
TETRAPHASE PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001373707, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-12, it reported annual revenue of USD 7,376,000; net income of USD -70,085,000; total assets of USD 36,385,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- TETRAPHASE PHARMACEUTICALS INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Watertown, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001373707
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $7.4M | -$70.1M | $36.4M | $21.2M | -$63.7M | |
| FY2018USD | $18.9M | -$72.2M | $122.9M | $107.8M | -$59.6M | |
| FY2017USD | $9.7M | -$114.8M | $149.0M | $136.4M | — | |
| FY2016USD | $5.1M | -$77.5M | $151.7M | $142.1M | — |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research TETRAPHASE PHARMACEUTICALS INC in Altss
Track this company’s investors, transactions and relationships in Altss.